HealthCare Royalty Partners
Spencer H. Schneider is the Chief Compliance Officer and Chief Patent Counsel at HCR. Mr. Schneider established HCR’s compliance program, handled all aspects of the Firm’s registration as an investment adviser with the SEC and manages all compliance functions. In addition, he functions as part of the transaction team, handling all investment-related intellectual property matters, throughout the investment and post-investment process. He is a registered patent attorney with extensive experience in conducting intellectual property due diligence for corporate transactions.
Prior to joining HCR, Mr. Schneider was a principal at Speyside Capital Advisors, a boutique advisory firm helping to facilitate commercialization of university inventions. Previously, Mr. Schneider was a senior lawyer in the intellectual property groups of Dewey & LeBoeuf, Ropes & Gray, and Cooper & Dunham. He has conducted patent due diligence for multiple types of transactions including public offerings, venture capital financings, mergers and acquisitions, leveraged buyouts, and royalty transactions.
Mr. Schneider holds a B.A. in Biology from Columbia College, a M.S. in Biochemistry and Molecular Biology from New York Medical College, and a J.D. from Cardozo School of Law.
This person is not in any offices
HealthCare Royalty Partners
HealthCare Royalty Partners (“HCR”) is a private investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage biopharmaceutical assets. They target healthcare assets with significant clinical value and strong barriers to entry that are meaningful to their marketer. They also look for assets that will produce sustainable revenues over an extended period of time. Their investments span the pharmaceutical, biotechnology, and specialty pharmaceuticals sectors.